Search clinical trials for: pitavastatin, valsartan, placebo

Total 54606 results

Novartis Pharmaceuticals

Completed

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

Hypertension

China
Stanford University
Novartis Pharmaceuticals

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Cerebrovascular Accident

United States
Novartis Pharmaceuticals

Completed

Special Drug Use Surveillance for Entresto Tablets

Chronic Heart Failure

Japan
Novartis Pharmaceuticals

Completed

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Mild and Moderate Renal Impairment

Russian Federation, Germany, Serbia
Novartis Pharmaceuticals

Completed

Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction

Hypertension With Renal Dysfunction

Japan
Novartis Pharmaceuticals

Completed

A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

Hepatic Impairment

Germany
Boehringer Ingelheim

Completed

SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

Hypertension | Diabetes Mellitus, Type 2

Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
JW Pharmaceutical

Completed

Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia (ESPRIT)

Hypercholesterolemia With Type2DM
Hanlim Pharm. Co., Ltd.

Completed

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

Healthy Male Subjects
Mostafa Bahaa
Sahar El-Haggar, Prof Clinical pharmacy Department- Tanta University; Osama... and other collaborators

Recruiting

Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

Diabetic Nephropathies

Egypt
Bayer

Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Hypertension

China, Korea, Republic of
Stanford University

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Stroke, Acute

United States
Novartis

Completed

A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Hypertension

Germany, Switzerland
Novartis

Completed

Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

De Novo Renal Transplantation
Novo Nordisk A/S

Completed

Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novartis Pharmaceuticals

Recruiting

Special Drug Use Surveillance of Entresto Tablets (Hypertension) (ENLIGHT)

Hypertension

Japan
Ain Shams University

Completed

Chronopharmacology of Valsartan in Normotensive Subjects

Healthy Normotensive Volunteers

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-drug Interaction of SP2086 and Valsartan

Type 2 Diabetes

China
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Osaka City University

Completed

Prevention of CHOP-induced Chronic Cardiotoxicity

Non-Hodgkin's Lymphoma

Japan
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Hypertension

Belgium, Turkey, Hungary, United States, Italy, India, Poland, France, South Africa, Brazil
Novartis Pharmaceuticals

Completed

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event (TRANSITION)

Heart Failure With Reduced Ejection Fraction

Italy, Czechia, Russian Federation, Saudi Arabia, Turkey, Belgium, Switzerland, United Kingdom, Spain, Canada, Lebanon, Germany, Slovakia, Portugal, France, Poland, Argentina, Norway, Sweden
Novartis

Completed

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Germany, Switzerland
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Kagoshima University

Unknown

Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) (KACT)

Hypertension | Obesity

Japan
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects

Type 2 Diabetes Mellitus

United States
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Hypertension

United States
Complexa, Inc.

Completed

A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males (DDI)

Acute Kidney Injury

United States
University of Oxford

Recruiting

REward Processing And Citalopram Study (REPAC)

Anhedonia

United Kingdom
Guangdong Provincial People's Hospital

Completed

A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

Glomerulonephritis | IGA Nephropathy

China
Novartis Pharmaceuticals

Completed

Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients

Severe Hypertension

Japan
Novartis

Completed

Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

Healthy

United States
Novartis

Completed

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Healthy

India
Brigham and Women's Hospital

Terminated

Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

Insulin Sensitivity | Diastolic Function | Aortic Compliance

United States
Novartis

Completed

Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.

Hypertension

Switzerland
Novartis

Completed

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

Hypertension | High Blood Pressure

Taiwan
Novartis

Completed

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

Hypertension

China
University of California, Irvine
United States Department of Defense

Active, not recruiting

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Chronic Lymphocytic Leukemia | AML, Adult | CLL | CLL, Relapsed | CLL, Refractory

United States
Guangdong Provincial People's Hospital

Unknown

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Type 2 Diabetes Mellitus | Nephropathy

China
University of Roma La Sapienza

Unknown

PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity (PORTO)

Coronary Artery Disease

Italy
Mohammed Alnims

Completed

Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients

Heart Failure With Reduced Ejection Fraction

Egypt
Central Hospital, Izmir

Unknown

Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment (CHILISALT)

Heart Failure With Reduced Ejection Fraction
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The DDI Study of SP2086 and Valsartan

Type 2 Diabetes

China
Novartis

Completed

To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

Hypertension | Diastolic Dysfunction

United States
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA) (GRAPPA)

HIV Infections

Netherlands
University College, London

Completed

Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer

Lung Cancer

United Kingdom
Hippocration General Hospital

Unknown

Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients (HEVRO)

Hypertension | Obesity

Greece
Forest Laboratories

Completed

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Hypertension

United States
Novartis

Completed

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients (EXAM)

Hypertension

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Essential Hypertension

China

3

Subscribe